The Afliliated Hospital of Guizhou Medical Univeristy
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
meng, dongtao
LBL-007-CN-004, NCT05516914: A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

Recruiting
1/2
490
RoW
LBL-007 Injection, LBL-007, Tislelizumab Injection, Tislelizumab, Cisplatin Injection, Cisplatin, Gemcitabine Hydrochloride for Injection, Gemcitabine Hydrochloride, Docetaxel injection, Docetaxel
Nanjing Leads Biolabs Co.,Ltd
Malignant Tumors
10/25
12/25
NCT06049290: A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

Recruiting
1/2
418
RoW
LBL-034 for Injection, LBL-034
Nanjing Leads Biolabs Co.,Ltd
Relapsed/Refractory Multiple Myeloma
10/26
05/27

Download Options